Skip to search formSkip to main contentSkip to account menu

Aspirin / Dipyridamole

Known as: Aspirin Dipyridamole Drug Combination, Combination, Aspirin-Dipyridamole Drug, ASPIRIN/DIPYRIDAMOLE 
A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Abstract Objectives To assess the risk of serious upper gastrointestinal bleeding associated with the newer antithrombotic agents… 
Highly Cited
2005
Highly Cited
2005
Background—Drugs that simultaneously decrease platelet function and inflammation may improve the treatment of cardiovascular… 
Highly Cited
1994
Highly Cited
1994
Hemodialysis (HD) vascular access thrombosis remains a major cause of morbidity, accounting for 17.4% of all HD patient hospital… 
Highly Cited
1988
Highly Cited
1988
Highly Cited
1987
Highly Cited
1987
Intimal dissection with acute closure represents the major complication associated with percutaneous transluminal coronary… 
Review
1986
Review
1986
To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind… 
Highly Cited
1984
Highly Cited
1984
To study the prevention of occlusion of aortocoronary-artery bypass grafts, we concluded a prospective, randomized, double-blind… 
Highly Cited
1984
Highly Cited
1984
Forty patients with Type I membranoproliferative glomerulonephritis were treated for one year with dipyridamole, 225 mg per day… 
Highly Cited
1982
Highly Cited
1982
To prevent occlusion of aortocoronary-artery-bypass grafts, we conducted a prospective, randomized-double-blind trial comparing… 
Highly Cited
1982
Highly Cited
1982
Levels of circulating platelet aggregates and plasma beta-thromboglobulin reflect the degree of platelet activation in vascular…